| In millions, except per share items | Dec-31-22 | Dec-31-21 |
| | 8-K | 10-K |
| Revenues | 145.9 | 2.8 |
| Revenue growth | 5204.6% | |
| Cost of goods sold | 86.6 | 1.2 |
| Gross profit | 59.3 | 1.5 |
| Gross margin | 40.6% | 54.6% |
| Selling, general and administrative [+] | 69.5 | 2.8 |
| Sales and marketing | 12.6 | |
| General and administrative | 56.9 | |
| Research and development | 50.1 | |
| Other operating expenses | 20.6 | -2.8 |
| EBITDA [+] | -73.1 | |
| EBITDA growth | -4964.2% | |
| EBITDA margin | -50.1% | 54.6% |
| Depreciation and amortization | 7.7 | |
| EBIT [+] | -80.8 | 1.5 |
| EBIT growth | -5479.4% | |
| EBIT margin | -55.4% | 54.6% |
| Non-recurring items [+] | -17.8 | 2.8 |
| Asset impairment | 2.8 | |
| Other income (expense), net [+] | -14.8 | -2.1 |
| Gain (loss) on investments | | 0.0 |
| Gain (loss) on foreign currency transactions | 0.3 | |
| Change in fair value of warrants | | -1.9 |
| Pre-tax income | -77.9 | -3.3 |
| Income taxes | 0.4 | 0.0 |
| Tax rate | | 0.0% |
| Net income | -78.3 | -3.3 |
| Net margin | -53.7% | -121.4% |
| |
| Basic EPS | | ($0.10) |
| Diluted EPS | | ($0.10) |
| |
| Shares outstanding (basic) | | 32.8 |
| Shares outstanding (diluted) | | 32.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |